Welcome to our dedicated page for Kemper SEC filings (Ticker: KMPB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kemper's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kemper's regulatory disclosures and financial reporting.
Kemper Corporation announced a leadership change. On October 14, 2025, the Board determined that Joseph P. Lacher, Jr. would depart as President and CEO, effective immediately, and he resigned from the Board the same day. He will serve as a non‑executive advisor through December 31, 2025 to support the transition.
The Board appointed C. Thomas Evans, Jr., age 66, as interim President and CEO, effective October 14, 2025. The Board formed a committee to identify the next CEO and plans to engage a global executive search firm.
In connection with a termination without cause, Mr. Lacher entered into a Separation and Release Agreement providing a cash severance of $5,720,000 (equal to two times base salary and target bonus), continued eligibility for a 2025 annual bonus based on actual financial goal achievement and target achievement of strategic goals, a lump sum equal to the employer portion of 24 months of healthcare coverage, and up to 12 months of outplacement services. Certain outstanding equity awards will remain outstanding and continue to vest per their terms, subject to compliance with restrictive covenants.